2021
DOI: 10.1021/acsmacrolett.1c00558
|View full text |Cite
|
Sign up to set email alerts
|

Cytosolic Delivery of Single-Chain Polymer Nanoparticles

Abstract: Cytosolic delivery of therapeutic agents is key to improving their efficacy, as the therapeutics are primarily active in specific organelles. Single-chain polymer nanoparticles (SCNPs) are a promising nanocarrier platform in biomedical applications due to their unique size range of 5–20 nm, modularity, and ease of functionalization. However, cytosolic delivery of SCNPs remains challenging. Here, we report the synthesis of active ester-functional SCNPs of approximately 10 nm via intramolecular thiol-Michael add… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(21 citation statements)
references
References 57 publications
0
20
0
Order By: Relevance
“…The size of SCNPs (generally <10 nm in diameter) is significantly smaller than that of conventional polymer nanocarriers and more akin to that of globular proteins or small viruses. The study of how this may affect the bioavailability of the drug encapsulated in SCNP carriers is still in the early stages but points to their increased cellular uptake compared to larger nanoparticles [26][27][28][29][30]. The successful encapsulation of small hydrophobic molecules has been carried out in covalently crosslinked SCNPs [26,31,32] as well as in self-folding amphiphilic SCNPs [33,34].…”
Section: Introductionmentioning
confidence: 99%
“…The size of SCNPs (generally <10 nm in diameter) is significantly smaller than that of conventional polymer nanocarriers and more akin to that of globular proteins or small viruses. The study of how this may affect the bioavailability of the drug encapsulated in SCNP carriers is still in the early stages but points to their increased cellular uptake compared to larger nanoparticles [26][27][28][29][30]. The successful encapsulation of small hydrophobic molecules has been carried out in covalently crosslinked SCNPs [26,31,32] as well as in self-folding amphiphilic SCNPs [33,34].…”
Section: Introductionmentioning
confidence: 99%
“…Single-chain polymer nanoparticles (SCNPs) are a charming kind of material due to their small size, modularity, and easy functionalization. [1] And they are prepared by an interesting method-folding a single linear polymer chain, [2][3][4] having potential applications in nanomedicine, [5,6] catalysis, [7,8] and sensing. [9,10] Owing to chain collapse, the formed SCNPs pockets provide a unique internal environment for the attachment of active species, such as drugs, catalysts, or dyes.…”
Section: Introductionmentioning
confidence: 99%
“…SCPNs are synthesized by performing intra-chain crosslinking reactions, where loops are introduced to the precursor polymer chains for compaction. 34,35 Recent researches [36][37][38][39][40] have demonstrated SCPNs' promise for cytosolic drug delivery but the fundamental study on the role of structural dynamics in cellular interactions to the best of our knowledge has been performed only via computational tools 20,41,42 . We have taken advantage of the recent advancement in the control and characterization of SCPNs 43,44,45 to produce nanoparticles with different degrees of structural dynamics.…”
Section: Introductionmentioning
confidence: 99%